Analysts Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) PT at $17.75
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, three have issued a buy recommendation and one has given […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, three have issued a buy recommendation and one has given […]
